Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-IL-6) in multiple myeloma

Jesús San-Miguel, Joan Bladé, Ofer Shpilberg, Sebastian Grosicki, Frédéric Maloisel, Chang Ki Min, Marta Polo Zarzuela, Tadeusz Robak, Sripada V.S.S. Prasad, Yeow Tee Goh, Jacob Laubach, Andrew Spencer, María Victoria Mateos, Antonio Palumbo, Tom Puchalski, Manjula Reddy, Clarissa Uhlar, Xiang Qin, Helgi Van De Velde, Hong XieRobert Z. Orlowskiإظهار 1 المزيدإظهار أقل